C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/06 (2006.01) A61K 31/505 (2006.01) C07D 401/14 (2006.01) C07D 403/14 (2006.01) C07D 405/14 (2006.01)
Patent
CA 2050994
X-7564 Abstract Novel substituted quinazolinones have been found to exhibit specific binding to cholecystokinin (CCK) receptors in the brain and/or peripheral site such as the pancreas and ileum. The quinazolinones are CCK receptor antagonists and find therapeutic application in the treatment of gastrointestinal disorders and central nervous system disorders, and are useful for appetite regulation in mammals. Pharmaceutical formulations for such indications are described.
Mccowan Jefferson Ray
Thrasher Kenneth Jeff
Yu Melvin Joseph
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1781193